Imunon, Inc. (IMNN)
1.555
0.00 (0.00%)
USD |
NASDAQ |
Sep 03, 16:00
1.555
0.00 (0.00%)
After-Hours: 19:36
Imunon Research and Development Expense (Annual) : 7.781M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 7.781M |
| December 31, 2024 | 11.64M |
| December 31, 2023 | 11.29M |
| December 31, 2022 | 11.73M |
| December 31, 2021 | 10.62M |
| December 31, 2020 | 11.34M |
| December 31, 2019 | 13.07M |
| December 31, 2018 | 11.87M |
| December 31, 2017 | 13.08M |
| December 31, 2016 | 14.62M |
| December 31, 2015 | 14.66M |
| December 31, 2014 | 14.97M |
| December 31, 2013 | 9.364M |
| December 31, 2012 | 15.77M |
| Date | Value |
|---|---|
| December 31, 2011 | 19.86M |
| December 31, 2010 | 14.71M |
| December 31, 2009 | 13.68M |
| December 31, 2008 | 12.01M |
| December 31, 2007 | 8.231M |
| December 31, 2006 | 9.345M |
| December 31, 2005 | 10.08M |
| December 31, 2004 | 9.542M |
| September 30, 2003 | 8.178M |
| September 30, 2002 | 5.004M |
| September 30, 2001 | 4.006M |
| September 30, 2000 | 2.238M |
| September 30, 1999 | 1.02M |
| September 30, 1998 | 1.535M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Phio Pharmaceuticals Corp. | 4.618M |
| Agenus, Inc. | 79.34M |
| Amgen, Inc. | 6.974B |
| Anika Therapeutics, Inc. | 25.77M |
| BioCryst Pharmaceuticals, Inc. | 164.74M |